DINESH V PH D PATEL, the President and CEO of $PTGX, sold 59 shares of the company on 03-24-2026 for an estimated $5,959. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.0% of their shares of this class of stock. Following this trade, they now own 524,938 shares of this class of $PTGX stock.
$PTGX Insider Trading Activity
$PTGX insiders have traded $PTGX stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $PTGX stock by insiders over the last 6 months:
- DINESH V PH D PATEL (President and CEO) has made 0 purchases and 7 sales selling 137,411 shares for an estimated $12,428,889.
- ASIF ALI (Chief Financial Officer) has made 0 purchases and 3 sales selling 54,791 shares for an estimated $4,549,375.
- ARTURO MD MOLINA (Chief Medical Officer) has made 0 purchases and 5 sales selling 35,377 shares for an estimated $2,919,916.
- WILLIAM D. WADDILL has made 0 purchases and 3 sales selling 32,000 shares for an estimated $2,653,080.
- LEWIS T WILLIAMS sold 18,000 shares for an estimated $1,483,560
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PTGX Hedge Fund Activity
We have seen 165 institutional investors add shares of $PTGX stock to their portfolio, and 172 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BVF INC/IL removed 2,560,916 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $223,670,403
- DEEP TRACK CAPITAL, LP removed 1,715,691 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $149,848,451
- JANUS HENDERSON GROUP PLC added 1,549,160 shares (+140.7%) to their portfolio in Q4 2025, for an estimated $135,303,634
- WELLINGTON MANAGEMENT GROUP LLP added 1,262,977 shares (+66.2%) to their portfolio in Q4 2025, for an estimated $110,308,411
- VANGUARD GROUP INC added 1,156,461 shares (+27.2%) to their portfolio in Q4 2025, for an estimated $101,005,303
- CITADEL ADVISORS LLC added 888,806 shares (+373.6%) to their portfolio in Q4 2025, for an estimated $77,628,316
- UBS GROUP AG added 874,013 shares (+46.1%) to their portfolio in Q4 2025, for an estimated $76,336,295
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PTGX Analyst Ratings
Wall Street analysts have issued reports on $PTGX in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Leerink Partners issued a "Outperform" rating on 03/19/2026
- Truist Securities issued a "Buy" rating on 01/05/2026
- Citigroup issued a "Buy" rating on 11/10/2025
- Citizens issued a "Market Outperform" rating on 11/07/2025
- Barclays issued a "Overweight" rating on 11/07/2025
- JP Morgan issued a "Overweight" rating on 11/07/2025
- BTIG issued a "Buy" rating on 10/28/2025
To track analyst ratings and price targets for $PTGX, check out Quiver Quantitative's $PTGX forecast page.
$PTGX Price Targets
Multiple analysts have issued price targets for $PTGX recently. We have seen 12 analysts offer price targets for $PTGX in the last 6 months, with a median target of $110.0.
Here are some recent targets:
- Brian Cheng from JP Morgan set a target price of $106.0 on 03/19/2026
- Faisal Khurshid from Leerink Partners set a target price of $110.0 on 03/19/2026
- Etzer Darout from Barclays set a target price of $119.0 on 03/19/2026
- Geoff Meacham from Citigroup set a target price of $125.0 on 03/19/2026
- Richard Law from Goldman Sachs set a target price of $95.0 on 03/03/2026
- Tara Bancroft from TD Cowen set a target price of $100.0 on 02/26/2026
- Jonathan Wolleben from Citizens set a target price of $112.0 on 02/26/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
